VEGF-C has been widely reported in lung cancer and is involved in lung cancer tumourigenesis and associated with lymphatic metastasis; it can be used as a biomarker for evaluating recurrence and prognosis in non-small cell lung cancer [29]. This evidence concerns the gene VEGFC and lung cancer.